Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39875

DTD1 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

DTD1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited human B lymphocyte population with targeted disruption of the D-tyrosyl-tRNA deacylase gene. In Raji cells, an EBV-transformed line derived from Burkitt's lymphoma, this model eliminates DTD1-mediated hydrolysis of D-aminoacyl-tRNAs, leading to D-amino acid misincorporation into proteins and proteotoxic stress. Key molecular interactors include D-aminoacyl-tRNAs, aminoacyl-tRNA synthetases, and the ribosome. The knockout enables translational fidelity studies, protein aggregation research, and disease modeling of neurodevelopmental disorders and B cell malignancies using assays such as D-tyrosine incorporation, proliferation analysis, and mass spectrometry.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DTD1

    Gene Identifier

    NCBI Gene ID 92675

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

DTD1 Knockout Raji Polyclonal Cells represent a polyclonal cell population derived from the human Raji B lymphocyte line, engineered via CRISPR/Cas9-mediated gene disruption to eliminate functional expression of the DTD1 gene. This heterogeneous knockout pool provides a versatile tool for investigating the consequences of DTD1 loss without clonal selection, preserving natural biological variability.

The Raji host cell line is an Epstein-Barr virus (EBV)-transformed lymphoblastoid cell line originating from a Burkitt’s lymphoma patient. These B lymphocytes retain key immunological features, including antigen presentation capabilities and robust proliferation, making them a standard model for studying B cell biology, immune surveillance, and lymphomagenesis.

DTD1 encodes a D-tyrosyl-tRNA deacylase that plays a critical role in translational fidelity by hydrolyzing D-aminoacyl-tRNAs, including D-tyrosyl-tRNA, thereby preventing their erroneous incorporation into nascent polypeptide chains. This enzyme interacts directly with D-aminoacyl-tRNAs and functions upstream of the ribosome, collaborating with aminoacyl-tRNA synthetases to safeguard protein synthesis. Disruption of DTD1 leads to the accumulation of aberrant D-amino acid-containing proteins, triggering proteotoxic stress, compromising proteome integrity, and activating cellular stress responses. DTD1 operates within the broader translational quality control network that involves tRNAs, aminoacyl-tRNA synthetases, ribosomes, and molecular chaperones.

In the context of Raji B lymphocytes, DTD1 loss-of-function disrupts translational quality control, potentially leading to proteotoxic stress that impacts cell proliferation, apoptosis, and immunoglobulin synthesis. Given the role of B cells in immune surveillance and the origin of Raji cells from Burkitt’s lymphoma, this knockout model enables exploration of how D-amino acid misincorporation contributes to lymphomagenesis and immune dysfunction. Additionally, as DTD1 mutations are associated with neurodevelopmental disorders such as intellectual disability and microcephaly, the Raji knockout population provides a tractable cellular platform for studying the fundamental consequences of D-aminoacyl-tRNA accumulation on protein homeostasis and cell viability.

Researchers can employ DTD1 Knockout Raji Polyclonal Cells for a wide array of functional studies. Typical assays include Western blotting and RT-qPCR to confirm DTD1 disruption, D-tyrosine incorporation and tRNA charging assays to quantify D-aminoacyl-tRNA levels, and mass spectrometry to detect D-amino acids in proteins. Functional consequences can be assessed via proliferation and apoptosis assays, flow cytometry, and immunofluorescence. This model is particularly suited for investigating translational fidelity, protein misfolding and aggregation, and the cellular impact of proteotoxic stress, with relevance to neurodevelopmental disorders and B cell malignancies. For personalized support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)